TABLE 1.
GTV | GTVln | CTV high-risk | CTV low-risk | CTVln high-risk | CTVln low-risk | |
CHCAM | 73.92 Gy/33f | 69.96 Gy/33f | 60.06 Gy/33f | 60.06 Gy/33f | 50.96 Gy/28f | |
FUSCC | 70.4 Gy/32f | 66 Gy/32f | 60 Gy/32f | 60 Gy/32f | 54 Gy/32f | |
FCH | 70.95 Gy/33f | 70.95 Gy/33f | 61.05 Gy/33f | 54.45 Gy/33f | 54.45 Gy/33f | |
SYSUCC | 69.96 Gy/33f | 68 Gy/33f | 60 Gy/33f | 54 Gy/33f | 60 Gy/33f | 54 Gy/33f |
SCH | 69.96 Gy/33f | 69.96 Gy/33f | 66 Gy/30f | 60 Gy/30f | 54 Gy/30f | |
Consensus | 70 Gy equivalent | 70 Gy equivalent | 70 Gy equivalent | Prophylactic dose (60 Gy) | 70 Gy equivalent | 50–60 Gy |
Abbreviations: GTV, gross tumor volume; GTVln, gross tumor volume for lymph nodes; CTV, clinical target volume; CTVln, clinical target volume for lymph nodes; CHCAM, the Cancer Hospital of Chinese Academy of Medical Science; FUSCC, the Fudan University Shanghai Cancer Center; FCH, Fujian Cancer Hospital; SYSUCC, the Sun Yat-sen University Cancer Center; SCH, the Sichuan Cancer Hospital.